FNY Investment Advisers LLC Acquires Shares of 6,000 Hinge Health Inc. $HNGE

Key Points

• FNY Investment Advisers LLC acquired 6,000 shares of Hinge Health Inc. ($HNGE) valued at approximately $310,000 in the 2nd quarter.
• Wall Street analysts have a generally positive outlook on Hinge Health, with price targets ranging from $56.00 to $64.00 and a consensus rating of "Moderate Buy."
• Despite a strong revenue increase of 54.9% year-over-year, Hinge Health reported a significant earnings miss with an EPS of ($13.10) compared to a consensus estimate of ($4.98).

FNY Investment Advisers LLC acquired a new position in Hinge Health Inc. (NYSE:HNGE - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 6,000 shares of the company's stock, valued at approximately $310,000.

Separately, CHURCHILL MANAGEMENT Corp purchased a new stake in Hinge Health in the 2nd quarter worth about $828,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on HNGE shares. KeyCorp lifted their price objective on Hinge Health from $45.00 to $60.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Robert W. Baird started coverage on Hinge Health in a report on Friday, September 5th. They issued a "neutral" rating and a $56.00 price objective for the company. Weiss Ratings reissued a "sell (d)" rating on shares of Hinge Health in a report on Wednesday, October 8th. Citizens Jmp assumed coverage on Hinge Health in a report on Monday, July 14th. They issued a "strong-buy" rating and a $58.00 price objective for the company. Finally, Bank of America raised their target price on Hinge Health from $42.00 to $64.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Hinge Health has a consensus rating of "Moderate Buy" and an average price target of $57.47.

Hinge Health Trading Down 2.3%

Shares of HNGE opened at $48.62 on Thursday. The firm's 50-day moving average is $54.40. Hinge Health Inc. has a twelve month low of $33.42 and a twelve month high of $62.18.

Hinge Health (NYSE:HNGE - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported ($13.10) earnings per share for the quarter, missing the consensus estimate of ($4.98) by ($8.12). The firm had revenue of $139.10 million during the quarter, compared to analysts' expectations of $125.16 million. During the same quarter in the previous year, the company posted ($0.96) EPS. The firm's revenue for the quarter was up 54.9% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS.

Hinge Health Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.